Market drivers The high unmet medical needs of Huntington's disease patients is a major growth driver for this market. Currently available treatments only provide symptomatic relief and do not halt or reverse the progression of the disease. This has accelerated research focus towards developing transformational gene therapies and pharmacological interventions. Rising healthcare expenditures per...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian